Lumantag, Riham A.
HRN: 10-09-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2024
CEFUROXIME 500MG (TAB)
09/24/2024
09/30/2024
PO
500 Mg
BID
Sp RMLE And Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes